Biotrend

What Biotrend does

Biotrend – Inovação e Engenharia em Biotecnologia, S.A. is a privately held Portuguese bioprocess development firm headquartered at Biocant Park in Cantanhede, founded in 2000 and operating as part of the A4F group. The company provides research-based services spanning bioprocess development, optimization, and scale-up, focused on industrial and marine biotechnology applications using natural or genetically modified microorganisms (bacteria, yeasts, fungi, protists, and microalgae) to produce biomass, chemicals, biopolymers, and recombinant enzymes from renewable raw materials.

Its service offering centers on three integrated capabilities: cultivation strategy development, advanced process optimization grounded in biological system dynamics, and process integration with raw material pre-processing and downstream processing. In-house infrastructure includes a development lab and pilot plant with bioreactors from 1 mL to 250L, complemented by partner-network access to facilities from 1,000L to 200,000L for industrial scale-up. A core proprietary asset is an aqueous-based extraction and purification process for PHBV and other PHA biopolyesters that enables downstream processing via extrusion and electrospinning, deployed across multiple EU consortia. The company holds ISO 9001:2015 certification (October 2024 audit by Bureau Veritas) and claims experience across more than 1,000 fermentation runs at various scales.

Biotrend operates a B2B professional services model generating revenue from direct client engagements and from participation in EU-funded collaborative research projects (H2020, Horizon Europe, and Portugal's PRR). Its client base spans small biotech startups to global corporations across industries including enzyme engineering, pulp and paper, marine biotech and cosmetics, agriculture and pest management, food and beverage, beverage, and pharmaceuticals. Distribution is direct (no intermediaries), with marketing through industry conferences (EFIB, Biomarine), LinkedIn, website content, and EU research networks. Founder Bruno Sommer Ferreira leads the company as CEO.

Name

Biotrend

Legal name

Biotrend – Inovação e Engenharia em Biotecnologia, S.A.

Website

https://biotrend.pt

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Biotrend is a private Portuguese bioprocess development firm offering cultivation strategy, process optimization, and scale-up services for industrial and marine biotechnology clients ranging from biotech startups to global corporations.

Ownership category

akta.pro rank

Product category

Bioprocess Development Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up) (IMAMALAL)

akta.pro secondary industries

Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL), Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA)

Keywords

• Bioprocess development
• Industrial biotechnology
• Microbial fermentation
• Biopolymer production
• Scale-up services

Headquarters

HQ city

Cantanhede

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Bioprocess development and optimization services: Research-based services for developing, optimizing, and scaling bioprocesses for clients, particularly in industrial and marine biotechnology. Services include cultivation strategy development, process integration, and advanced optimization based on biological system dynamics.
2. Process scale-up, de-risking and validation services: Scale-up studies and process de-risking services using available bioreactors (2L, 10L, 50L, 250L) with access to industrial-scale facilities (1,000L to 200,000L) through partner network.
3. Collaborative research project participation: Participation in funded collaborative research projects under EU programs (H2020, national PRR) where Biotrend contributes specific expertise and receives project funding for R&D activities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Biotrend is a research-based company providing bioprocess development, optimization, and scale-up services for industrial and marine biotechnology. It works with natural or genetically modified microorganisms (bacteria, yeasts, fungi, protists, microalgae) and renewable raw materials to produce biomass, chemicals, biopolymers, and recombinant enzymes. Services span cultivation strategy design, advanced process optimization, process integration, and scale-up from 2L bioreactors to industrial 200,000L capacity via partner networks.

Product overview

Biotrend is a research-based company offering bioprocess development, optimization, and scale-up services for industrial biotechnology applications. The company operates a single integrated service model centered on advanced bioprocessing know-how, providing Process Development and Optimization Services and Process Scale-up, De-risking and Validation Services as its core offerings. These services are delivered through a state-of-the-art pilot plant infrastructure and leveraged across multiple collaborative research projects including CiNTech (nucleic acid production for injectables), PACTO DA BIOECONOMIA AZUL (biopolyester production from microalgae), MOVE2LOWC (biofuel fermentation), VOLATILE (VFA platform), FUNGUSCHAIN (biopolyester conversion), YPACK and RES-URBIS (PHA purification), ELLIPSE (PHA from waste), OLEFINE (insect pheromones), DAFIA (dicarboxylic acids), SPILLESS (bioremediation), INCOVER and SMART-PLANT (wastewater biopolymer recovery). The company also provides proprietary aqueous-based PHA purification technologies used across multiple projects. Biotrend works with diverse microorganisms (bacteria, yeasts, fungi, protists, microalgae) to produce biomass, chemicals, biopolymers, and recombinant enzymes from renewable raw materials.

Differentiator

Problem solved

Functional benefit

Products and services

• Process Development and Optimization Services Bioprocess development and optimization services including cultivation strategy design, advanced process optimization based on biological system dynamics, and process integration with raw material pre-processing and downstream processing. Aimed at clients needing cost-competitive, robust industrial-scale bioprocesses.
• Process Scale-up, De-risking and Validation Services Scale-up studies and process de-risking using in-house 2L, 10L, 50L, and 250L bioreactors with direct access to facilities from 1,000L to 200,000L fermentation capacity through a partner network. Designed for thorough scale-up and industrial validation.
• Bioprocess Consulting Expert bioprocessing consulting for cost-competitive and robust industrial-scale bioprocess design, serving clients from small biotech startups to global corporations.
• CiNTech – Microbial Fermentation for Nucleic Acid Production Development and scale-up of microbial fermentation processes for nucleic acid production for complex injectable medicines, including state-of-the-art macromolecule purification techniques. Part of the CiNTech consortium with Bluepharma.
• PACTO DA BIOECONOMIA AZUL – Biopolyester Production Development, optimization, and scale-up of fermentation processes for biodegradable biopolyesters from microalgae-derived starch, with aqueous-based extraction and purification processes.
• MOVE2LOWC – Biofuel Fermentation Optimization and scale-up of fermentation processes for conversion of lignocellulosic hydrolysates into lipids for biofuel production using oleaginous yeasts (in partnership with A4F AlgaFuel).
• Fermentation Infrastructure Services State-of-the-art development lab and bioprocessing pilot plant with fermentation scale from 1 mL to 250L, including 9x 2L, 2x 10L, 2x 50L, 1x 250L bioreactors and comprehensive analytics equipment.

Quantifiable outcome

• Reduction of raw materials cost by more than 80% for industrial enzyme production
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Bluepharma (CiNTech consortium)coreStrategic or Co-development Partner · 1 January 2023CiNTech project aims to establish the first Technological Pole for Innovation, Translation, and Industrialization dedicated to complex injectable drugs. Biotrend leads development and scale-up of microbial fermentation processes for nucleic acid production. Total investment €29.5M, Biotrend investment €1.5M.
• Inovamar (PACTO DA BIOECONOMIA AZUL)coreStrategic or Co-development PartnerBlue Bioeconomy Pact promoting sustainable blue bioeconomy paradigm. Biotrend develops fermentation processes for biodegradable biopolyesters from microalgae-derived starch. Total investment €133M, Biotrend incentive €707K.
• A4F AlgaFuel (MOVE2LOWC consortium)coreStrategic or Co-development PartnerMOVE2LOWC project for biofuel production for aviation and heavy road transport. Biotrend optimizes fermentation processes converting lignocellulosic hydrolysates into lipids using oleaginous yeasts. Project total €8.3M, EU aid €4.6M.
• APQuímica / EngIQ ProgramminorStrategic or Co-development PartnerEngIQ Doctoral and Advanced Training Program connecting academia and industry. Biotrend hosts PhD students at Biocant Park. 15-year program with 82 PhD students admitted, 47 completed doctorate.
• GalpminorStrategic or Co-development PartnerHost company for EngIQ program anniversary event. Major Portuguese energy company involved in chemical industry transformation initiatives.
• H2020 Research Consortium Partners (VOLATILE, FUNGUSCHAIN, YPACK, RES-URBIS, INCOVER, SMART-PLANT, ELLIPSE, OLEFINE, DAFIA)coreStrategic or Co-development PartnerMultiple EU-funded collaborative research projects: VOLATILE (VFA platform), FUNGUSCHAIN (mushroom residue valorization), YPACK (PHA food packaging), RES-URBIS (urban bio-waste conversion), INCOVER (wastewater treatment), SMART-PLANT (wastewater plant renovation), ELLIPSE (slaughterhouse/paper waste to PHA), OLEFINE (insect pheromones), DAFIA (municipal waste to flame retardants). Biotrend provides proprietary aqueous-based PHA purification technologies.
• SPILLESS Consortium PartnersminorStrategic or Co-development PartnerBlue Lab project for bioremediation of oil spills using native microbial consortia. Biotrend developing robust process for microbial consortia production with enhanced shelf-life.
• Scale-up facility partnerscoreOthersNetwork of partners providing access to facilities from 1,000L to 200,000L fermentation capacity for process scale-up and industrial validation.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/939475

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotrend